
A phase 3 lung-fibrosis drug preserved breathing better than placebo.
The lower dose met the trial’s main goal over 52 weeks. The higher dose did not, and the detailed results are not yet published.
Every serving. No expiration date. Page 3 of 5.

The lower dose met the trial’s main goal over 52 weeks. The higher dose did not, and the detailed results are not yet published.

Demand broke records. The emergency alerts did not arrive. Since 2023, Texas added 19.5 GW of solar and 16 GW of battery storage.

Eight practical modules help communities turn names, skills and local knowledge into a plan before the next disruption arrives.

Five years, a 27% decline, and a health system still pushing: Rwanda is pairing community care with faster records and referrals.

A six-month pilot will replace gasoline generators with batteries, cutting fumes and noise while gathering real-world data for thousands of street vendors.

The first 33-megawatt block is earning revenue under a power-purchase agreement. Two more blocks are due to complete the 100-megawatt first phase.

WHO/Europe calls the result an early signal: the evaluation covers five months and independent peer review is pending.

SB 868 treats certified portable solar more like a household appliance: utilities may require a simple online registration, but not prior approval.

The 3–2 ruling invalidated an expansion approval after the planning commission focused on only 2% of projected emissions and did not consider conditions for the other 98%.

Project MedBridge moved about 50 pallets of unopened N95 respirators and therapy packs into a distribution network serving underresourced health facilities.

In a 10-person safety trial, an experimental optogenetic treatment produced clinically meaningful light-sensitivity gains in six participants. It did not restore normal sight.

Human lung organoids retained resident T cells, recognized SARS-CoV-2 and responded more strongly after a simulated booster.

Functional testing on skin cells helped close difficult mitochondrial-disease diagnoses across samples from more than 30 medical centres.

The pollinators carried a precise biological treatment to as many as 88% of flowers.

Panels make power now. Molten salt is designed to hold heat for later.

At 90,000–120,000 miles, EVs were about 25% less likely to fail an MOT.

Two fins. One layer of living muscle. A light to follow.

The fabric let light, rain and air through — while keeping insect mouths out.

Old batteries, panels and blades are starting to feed the next buildout.

Three remote counseling sessions and a phone tool helped young people make safer decisions in a rigorous trial.

An 80-foot hoist, one deputy on the wire and a crew that did not waste a second.

The clean-power buildout turned into an energy-security shield when global gas prices spiked.

Four weeks of at-home magnetic-field sessions produced encouraging early signals for long-COVID cognitive impairment.

A small trial suggests the first medication for lymphedema may be getting closer.